Chronic liver failure
ICD-10 K72.1 · ICD-11 DB99.8

Treatment of Chronic Liver Failure with Hepatic Hydrothorax in Decompensated Cirrhosis

Hepatic hydrothorax is a specific complication of decompensated liver cirrhosis defined by the accumulation of pleural transudate in the absence of primary cardiopulmonary or pleural disease. Its management requires a protocol tailored to the underlying liver condition and the patient's clinical status.

Clinical scenario Decompensated cirrhosis with hepatic hydrothorax (pleural transudate) in the absence of cardiopulmonary or primary pleural disease.

Treatment Approach

When hepatic hydrothorax becomes refractory and certain interventions are not feasible options, a pleural-directed procedure may be considered for carefully selected patients. Patient selection for this approach is critical due to the risk of associated side effects.

The complete protocol — covering full eligibility criteria, procedural considerations, contraindications, and clinical sequencing — is available below.

References

DOI: 10.1016/j.jhep.2018.03.024

Hepatic hydrotorax describes the accumulation of transudate in the pleural space of patients with decompensated cirrhosis in the absence of cardiac, pulmonary or pleural disease.

Pleurodesis can be suggested to patients with refractory hepatic hydrothorax not amenable to LT or TIPS insertion. However, the frequent occurrence of side effects related to this technique restricts its use to selected patients (I;2).

View source ↗